Loading...

Financial Summary


AquaBounty Technologies Inc.

AquaBounty Technologies Inc. (AQB)

Healthcare
Neutral
B
Market Info
Financial Info
Financial Modelling
Symbol AQB
Price 3.9$
Beta 0.45
Volume Avrg. 0.17M
Market Cap 0.05B
Shares (2018) 13,028.76K
Last Div 0
Dividend Yield -
DCF Unlevered -
DCF Levered -
ROE -44.68% Strong Sell
ROA -39.46% Strong Sell
Operating Margin -12264.60% Strong Sell
Debt / Equity 15.46% Neutral
P/E - Neutral
P/B 1.28 Strong Buy

Income Statement

Download AQB income statement Download AQB income statement
Year 20112012201320142015201620172018
Revenue ------0.050.08
Cost of Revenue ------0.050.08
Gross Profit ------0.000.01
R&D Expenses 2.171.631.903.213.343.433.373.46
Sales, General and Administrative Expense 3.252.682.983.923.694.645.866.91
Operating Expenses 5.424.414.887.147.038.079.2310.37
Operating Income -5.42-4.41-4.88-7.14-7.03-8.07-9.23-10.37
Interest Expense 0.000.010.000.000.000.400.020.02
Earnings before Tax -2.71-4.41-4.69-7.13-7.03-8.47-9.26-10.38
Income Tax Expense --------
Net Income -2.71-4.41-4.69-7.13-7.03-8.47-9.26-10.38
Net Income - Non-Controlling int --------
Net Income - Discounted ops --------
Net Income Com -2.71-4.41-4.69-7.13-7.03-8.47-9.26-12.20
Preferred Dividends -------1.82
Earnings Per Share Basic -1.20-1.50-1.20-1.52-1.40-1.60-1.06-0.94
Earnings Per Share Diluted -1.20-1.50-1.20-1.52-1.40-1.60-1.06-0.94
Weighted Average Shares Outstanding 2.283.154.024.685.045.308.7713.03
Weighted Average Shares Outstanding (Diluted) 2.283.154.024.685.045.308.7713.03
Dividend per Share --------
Gross Margin ------0.050.08
EBITDA Margin -------169.90-112.60
EBIT Margin -------173.38-122.58
Profit Margin -------173.78-144.41
Free Cash Flow margin -------0.00-0.00
EBITDA -2.49-4.18-4.54-6.99-6.93-7.91-9.05-9.52
EBIT -2.71-4.41-4.69-7.13-7.03-8.07-9.24-10.36
Consolidated Income -2.71-4.41-4.69-7.13-7.03-8.47-9.26-10.38
Earnings Before Tax Margin -------173.78-122.84
Net Profit Margin -------173.78-122.84

Balance Sheet Statement

Download AQB income statement Download AQB income statement
Year 201220132015201620172018
Cash and cash equivalents 0.351.881.313.320.492.99
Short-term investments 0.010.010.010.010.010.01
Cash and short-term investments 0.361.891.323.340.513.00
Receivables 0.020.080.040.160.180.12
Inventories ----0.170.08
Property, Plant & Equipment Net 1.131.020.741.7221.8023.72
Goodwill and Intangible Assets 0.290.330.400.390.380.36
Long-term investments ------
Tax assets ------
Total non-current assets 2.032.362.072.653.033.52
Total current assets 1.451.371.162.1422.3424.16
Total assets 1.963.562.645.7123.7327.67
Payables 0.440.700.621.022.670.82
Short-term debt 0.27--0.020.050.07
Total current liabilities 0.710.700.621.042.720.92
Long-term debt 2.032.362.072.653.033.52
Total debt 2.312.362.072.663.083.59
Deferred revenue ------
Tax Liabilities ------
Deposit Liabilities ------
Total non-current liabilities 2.032.362.072.653.033.52
Total liabilities 2.743.062.693.685.754.44
Other comprehensive income -0.66-0.57-0.23-0.29-0.21-0.57
Retained earnings (deficit) -71.96-76.64-90.80-99.27-108.53-118.91
Total stockholders equity ------
Investments 0.010.010.010.010.010.01
Net Debt 1.940.470.75-0.672.580.59
Other Assets 0.130.220.110.070.530.32
Other Liabilities -----0.02

Cash Flow Statement

Download AQB income statement Download AQB income statement
Year 20112012201320142015201620172018
Depreciation & Amortization 0.210.230.150.140.110.150.180.84
Stock-based compensation 0.250.320.140.270.240.220.120.26
Operating Cash Flow -4.95-3.72-4.46-6.56-6.75-7.45-9.10-9.82
Capital Expenditure -0.07-0.05-0.10-0.12-0.07-1.07-19.05-4.08
Acquisitions and disposals --------
Investment purchases and sales 3.530.00-0.00-----
Investing Cash Flow --------
Insurance (repayment) of debt --------
Insurance (buybacks) of shares --------
Dividend payments --------
Financing Cash Flow 0.552.556.1310.023.0410.5425.2416.45
Effect of forex changes on cash 0.000.000.00-0.02-0.04-0.010.08-0.05
Net cash flow / Change in cash -0.95-1.281.533.29-3.852.01-2.832.50
Free Cash Flow -5.02-3.77-4.56-6.68-6.82-8.52-28.15-13.90
Net Cash/Marketcap 0.000.000.000.000.000.00-0.00-0.00

Retained Earning Schedule

Year 201220132015201620172018
Retained Earnings (Previous Year) --72--91-99-109
Net Income -4-5-7-8-9-10
Stock Dividends -68--84---
Divident Paid ------
Retained Earnings -72-77-91-99-109-119
Year 201220132015201620172018
Gross PPE -1-1222
Annual Depreciation 1-012396
Capital Expenditure -0-0-0-1-19-4
Net PPE 11122224

Intangible and Goodwill Schedule

Year 201220132015201620172018
Intangible and Goodwill (Previous Year) -0-000
New Purchases 0-0----
Intangible and Goodwill 000000
AquaBounty Technologies Inc.

AquaBounty Technologies Inc. (AQB)

3.9
-0.01 (-0.26%)

About


Ronald L Stotish
Healthcare
Biotechnology
NASDAQ Capital Market

AquaBounty Technologies Inc is a biotechnology company. The Company is engaged in the business of conducting research and development of the commercial viability of a group of proteins known as antifreeze proteins.